Lusaris Therapeutics
San Diego, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $60M
Overview
A biotech developing optimized neuroplastogenic medicines for neuropsychiatric disorders.
PsychiatryNeuroscience
Technology Platform
A medicinal chemistry platform focused on designing novel neuroplastogenic small molecules with optimized pharmacological profiles for neuropsychiatric indications.
Funding History
1Total raised:$60M
Grant$60M
Opportunities
Tapping into the multibillion-dollar depression and anxiety market with a potentially paradigm-shifting treatment that offers rapid and sustained efficacy.
Risk Factors
Faces significant clinical, regulatory, and commercial risks associated with a novel drug class and the need to demonstrate a superior risk-benefit profile.
Competitive Landscape
Competes in the psychedelic-inspired therapeutics sector against both public and private companies (e.g., Compass Pathways, Cybin, Atai Life Sciences).